logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
J

Jan Philipp Bewersdorf

department of internal medicine

34H指数
266论文数
3.6K被引数
收录论文 90
发表时间
logo
Defining and predicting disease progression in myeloproliferative neoplasms: a proposed biomarker-driven approach定义和预测骨髓增殖性肿瘤的疾病进展：一种基于生物标志物驱动的方法
errLeukemia
IF13.4
err2026-09-01
err0
errOAAI
errRaajit K. Rampal; Richard Winneker; Andrew Kuykendall; Laura C. Michaelis; Ghaith Abu-Zeinah; Steffen Koschmieder; Jan Philipp Bewersdorf; Zi Yun Ng; Gabriella Hobbs; Bridget Marcellino; Linda Resar; Joseph Scandura; Anand Patel; John Mascarenhas; Aaron Gerds; Douglas Tremblay; Shane Mayack; Andriy Derkach; Florian H. Heidel
err分享
err收藏
Choice of hypomethylating agent for newly diagnosed TP53-mutant acute myeloid Leukemia: a COMMAND registry study
errLeukemia
IF13.4
err2026-08-31
err0
PREAI
errTalha Badar; James Foran; Omer Jamy; Chenyu Lin; Anand Patel; Yu-Hung Wang; Mahesh Kumar; Rory M. Shallis; Kendall Diebold; Alexander Coltoff; Aaron D. Goldberg; Jan P. Bewersdorf; Kenneth M. Zabel; Charles Foucar; Yasmin Abaza; Guru S. Murthy; Neil Palmisiano; Adam S. DuVall; Vamsi Kota; Shyam A. Patel; Amer M. Zeidan; Hemant Murthy; Mohamed Kharfan-Dabaja; Ehab Atallah; Mark R. Litzow
err分享
err收藏
Impact of Response to Hypomethylating Agent-Based Therapy on Survival Outcomes in the Context of Baseline Clinical-Molecular Risk and Transplant Status in Patients With Higher-Risk Myelodysplastic Syndromes/Neoplasms: An analysis From the International Consortium for MDS (icMDS)基于低甲基化制剂治疗的反应对高风险骨髓增生异常综合征/肿瘤患者生存结局的影响：考虑基线临床-分子风险和移植状态的国际骨髓增生异常综合征联盟(icMDS)分析
errAmerican Journal of Hematology
IF9.9
err2026-08-28
err0
PREAI
errBenjamin Rolles; Jan Philipp Bewersdorf; Tariq Kewan; Ondrej Blaha; Jessica M. Stempel; Luca Lanino; Najla H. Al Ali; Amy E. DeZern; Mikkael A. Sekeres; Geoffrey L. Uy; Samuel Urrutia; Hetty E. Carraway; Pinkal Desai; Elizabeth A. Griffiths; Eytan M. Stein; Andrew M. Brunner; Christine McMahon; Rory M. Shallis; Joshua F. Zeidner; Michael R. Savona; Shougat Barua; Namrata Sonia Chandhok; Constantine Logothetis; Aram Bidikian; Ted M. Getz; Gail J. Roboz; Eunice S. Wang; Amyah C. Harris; Maria L. Amaya; Hayley Hawkins; Somedeb Ball; Justin Grenet; Parisa Abedi; Shai Shimony; R. Coleman Lindsley; Zhuoer Xie; Yazan F. Madanat; Yasmin Abaza; Talha Badar; Torsten Haferlach; Jaroslaw P. Maciejewski; David Sallman; Anoop Enjeti; Kamal Al-Rabi; Khalid Halahleh; Devendra Hiwase; Maria Diez-Campelo; David Valcarcel; Claudia Haferlach; Lisa Pleyer; Ioannis Kotsianidis; Vasiliki Pappa; Valeria Santini; Angela Consagra; Aref Al-Kali; Seishi Ogawa; Yasuhito Nannya; Matteo Giovanni Della Porta; Rami S. Komrokji; Amer M. Zeidan; Maximilian Stahl
err分享
err收藏
Outcomes of patients with higher-risk myelodysplastic syndromes/neoplasms treated with hypomethylating agents + venetoclax—an analysis from the International Consortium for MDS (icMDS) VALIDATE database高风险骨髓增生异常综合征/新生物患者接受去甲基化药物+维奈克拉治疗后的结局分析——国际骨髓增生异常综合征（icMDS）VALIDATE数据库分析
errBlood Cancer Journal
IF11.6
err2026-06-29
err0
errOAAI
errJan Philipp Bewersdorf; Tariq Kewan; Luca Lanino; Wei Wei; Tulika Rudra Gupta; Jessica M. Stempel; Najla H. Al Ali; Amy E. DeZern; Mikkael A. Sekeres; Geoffrey L. Uy; Samuel Urrutia; Hetty E. Carraway; Pinkal Desai; Elizabeth A. Griffiths; Eytan M. Stein; Andrew M. Brunner; Christine McMahon; Rory M. Shallis; Joshua F. Zeidner; Michael R. Savona; Hayley Hawkins; Namrata Sonia Chandhok; Constantine N. Logothetis; Aram Bidikian; Ted M. Getz; Gail J. Roboz; Benjamin Rolles; Eunice S. Wang; Amyah C. Harris; Maria L. Amaya; Somedeb Ball; Justin Grenet; Zhuoer Xie; Yazan F. Madanat; Yasmin Abaza; Talha Badar; Jaclynn Campos; Torsten Haferlach; Jaroslaw P. Maciejewski; David Sallman; Anoop Enjeti; Kamal Al-Rabi; Khalid Halahleh; Devendra Hiwase; Maria Diez-Campelo; David Valcarcel; Claudia Haferlach; Lisa Pleyer; Ioannis Kotsianidis; Vassiliki Pappa; Valeria Santini; Angela Consagra; Aref Al-Kali; Seishi Ogawa; Yasuhito Nannya; Maximilian Stahl; Matteo Giovanni Della Porta; Rami S. Komrokji; Amer M. Zeidan
err分享
err收藏
Acute myeloid leukemia after myeloproliferative neoplasms: Real-world outcomes in the new treatment era in the United States骨髓增殖性肿瘤后的急性髓系白血病：美国新治疗时代的真实世界结果
errCancer
IF5.1
err2026-04-25
err0
PREAI
errJan Philipp Bewersdorf MD; Rong Wang PhD; Lourdes Mendez MD, PhD; Alain Mina MD; Luis E. Aguirre MD; Maximilian Stahl MD; Amer M. Zeidan MBBS, MHS; Xiaomei Ma PhD; Nikolai A. Podoltsev MD, PhD
err分享
err收藏
Current Landscape and Future Directions for Treatment of Accelerated-Phase and Blast-Phase Myeloproliferative Neoplasms加速期和原始细胞期骨髓增殖性肿瘤的治疗现状与未来方向
errSeminars in Hematology
IF4.1
err2026-04-19
err0
PREAI
errRohan K. Achar; Jan Philipp Bewersdorf
err分享
err收藏
A 2026 update on myelodysplastic neoplasms: current state, challenges and future directions2026年骨髓增生异常肿瘤的最新进展：当前状态、挑战与未来方向
errNature Reviews Clinical Oncology
IF82.2
err2026-04-14
err0
PREAI
errJan Philipp Bewersdorf; Alain Mina; Maximilian Stahl; Amer M. Zeidan
err分享
err收藏
Learning from late-stage trial failures in higher-risk myelodysplastic syndromes: towards adaptive and biomarker-enriched designs从高风险骨髓增生异常综合征晚期试验失败中学习：迈向适应性设计和生物标志物富集设计
errExpert Review of Anticancer Therapy
IF2.8
err2026-03-04
err0
PREAI
errAmer M. Zeidan; Sofia Aakko; Maximilian Stahl; Jan P. Bewersdorf; Petri Bono; Teppo Huttunen; Juho Jalkanen; Elina Louramo; Aneel Nimba; Joab Williamson
err分享
err收藏
Risk stratification of patients with TP53-mutated myeloproliferative neoplasmsTP53突变骨髓增殖性肿瘤患者的风险分层
errLeukemia
IF13.4
err2026-02-24
err0
PREAI
errBenjamin Rolles; Cilomar Martins de Oliveira Filho; Nathan Fergusson; Jan Philipp Bewersdorf; Julia Keating; Cecelia Perkins; Matthew Schwede; James England; Marlise R. Luskin; Daniel J. DeAngelo; Shai Shimony; Mifra Faiz; Addison C. Hillerbrand; Chulwoo Kim; Lachelle D. Weeks; Lauren Waldman; Mohammed Wazir; Joan How; Anna E. Marneth; Yiwen Liu; Martin J. Aryee; Raajit Rampal; Harrison K. Tsai; Jason Gotlib; Vikas Gupta; Maximilian Stahl; Ann Mullally
err分享
err收藏
The global epidemiology of acute myeloid leukaemia急性髓性白血病的全球流行病学
errNature Reviews Clinical Oncology
IF82.2
err2025-12-05
err0
PREAI
errFiras El Chaer; Jan P. Bewersdorf; Maximilian Stahl; Amer M. Zeidan
err分享
err收藏
Isavuconazole provides effective and tolerable antifungal prophylaxis for patients with acute myeloid leukemia伊沙库唑唑为急性髓系白血病患者提供了有效且耐受性良好的抗真菌预防。
errLEUKEMIA RESEARCH
IF2.2
err2025-12-01
err0
PREAI
errHunter, Cameron J.; Chou, Andrew; Roeder, Heidi; Eighmy, William; Bewersdorf, Jan Philipp; Mendez, Lourdes; Stahl, Maximilian; Podoltsev, Nikolai A.; Zeidan, Amer M.; Shallis, Rory M.
err分享
err收藏
Outcomes of older patients with TP53-mutated myeloid neoplasmsTP53突变髓系肿瘤老年患者的结局
errBlood Cancer Journal
IF11.6
err2025-10-07
err0
errOAAI
errOmer Jamy; Mobachir El Kettani; Kashish Shah; Rory M. Shallis; Kendall Diebold; Alexander Coltoff; Aaron D. Goldberg; Anand Patel; Jan P. Bewersdorf; Charles Foucar; Yasmin Abaza; Neil Palmisiano; Adam S. DuVall; Vamsi Kota; Shyam A. Patel; Amer M. Zeidan; Ehab Atallah; Mark R. Litzow; Talha Badar
err分享
err收藏
Feasibility, safety and outcomes of patients with newly diagnosed acute myeloid leukemia discharged 'early' after intensive induction
errLEUKEMIA & LYMPHOMA
IF2.2
err2025-10-01
err0
PREAI
errHunter, Cameron J.; Cheng, Wei; Bewersdorf, Jan Philipp; Boddu, Prajwal; Browning, Sabrina; Halene, Stephanie; Parker, Terri; Huntington, Scott F.; Kothari, Shalin; Mendez, Lourdes; Neparidze, Natalia; Sethi, Tarsheen; Barbarotta, Lisa; Podoltsev, Nikolai A.; Zeidan, Amer M.; Shallis, Rory M.
err分享
err收藏
Luspatercept for Patients with Lower-Risk Myelodysplastic Syndromes/Neoplasms: A Systematic Review and Meta-Analysis.Luspatercept在低风险骨髓增生异常综合征/肿瘤患者中的应用：一项系统评价和Meta分析。
errBlood Advances
IF7.1
err2025-09-23
err0
errOAAI
errAbdulrahman Alhajahjeh; Naira Woite; Benjamin Rolles; Jessica M. Stempel; Alain Mina; Lourdes Mendez; Tariq Kewan; Nikolai A. Podoltsev; Maximilian Stahl; Alyssa A. Grimshaw; Amer M. Zeidan; Jan Philipp Bewersdorf
err分享
err收藏
Hypomethylating Agent and Venetoclax Combination Is a Safe and Effective Alternative to Intensive Chemotherapy in Older (≥ 70 Years) Patients With Newly Diagnosed Favorable Risk Acute Myeloid Leukemia去甲基化药物与Venetoclax联合方案是老年（≥70岁）新诊断低危急性髓系白血病患者接受强化化疗的安全有效替代方案。
errAmerican Journal of Hematology
IF9.9
err2025-08-07
err0
PREAI
errSomedeb Ball; Akriti G. Jain; Najla Al Ali; Luis E. Aguirre; Jan Philipp Bewersdorf; Andrew Kent; Ameera Rose; Alexander Hayden; Alexa Siddon; Jill Lykon; Ellen Madarang; David M. Swoboda; Eric Padron; Kendra Sweet; David A. Sallman; Jeffrey Lancet; Hetty E. Carraway; Justin Watts; Amer Zeidan; Daniel A. Pollyea; Rami S. Komrokji
err分享
err收藏
Cost-Effectiveness of Upfront vs. Delayed Allogeneic Hematopoietic Stem Cell Transplant for Intermediate Risk AML异基因造血干细胞移植在治疗中期风险急性髓系白血病中的成本效益：即刻移植与延迟移植的比较
errBlood Advances
IF7.1
err2025-08-06
err0
errOAAI
errAbdulrahman Alhajahjeh; Kishan K. Patel; Nikolai A. Podoltsev; Tariq Kewan; Jessica M. Stempel; Lourdes Mendez; Stuart Seropian; Lohith Gowda; Scott F. Huntington; Maximilian Stahl; Amer M. Zeidan; George Goshua; Jan Philipp Bewersdorf
err分享
err收藏
Integrated Immune Landscape Analysis of RNA Splicing Factor-Mutant AML and Higher risk MDS Treated with Azacitidine ± DurvalumabRNA剪接因子突变AML和高风险MDS接受阿扎胞苷±度鲁瓦图单抗治疗后的整合免疫景观分析
errTherapeutic Advances in Hematology
IF3.1
err2025-06-21
err0
errOAAI
errJan Philipp Bewersdorf; Vanessa Hasle; Rory M. Shallis; Ethan Thompson; Daniel Lopes de Menezes; Shelonitda Rose; Isaac Boss; Lourdes Mendez; Nikolai Podoltsev; Maximilian Stahl; Tariq Kewan; Stephanie Halene; Torsten Haferlach; Brian A. Fox; Amer M. Zeidan
err分享
err收藏
Heterogeneity in outcomes of TP53-mutated myeloproliferative neoplasms based on disease phenotype and mutational statusTP53突变性骨髓增殖性肿瘤的结局异质性，基于疾病表型和突变状态
errBRITISH JOURNAL OF HAEMATOLOGY
IF3.8
err2025-05-22
err0
PREAI
errTalha Badar; James M. Foran; Jan Philipp Bewersdorf; Yu-Hung Wang; Alexander Coltoff; Mobachir El Kettani; Kashish Shah; Francyess Denis Oliva; Chenyu Lin; Omer Jamy; Kendall Diebold; Rory M. Shallis; Alexa Siddon; Daniil Katkov; Alexa Schoen; Irum Khan; Charles E. Foucar; Ehab Atallah; Aaron D. Goldberg; Anand A. Patel
err分享
err收藏
Imetelstat in myeloid malignancies: current data and future directions伊美特尔stat在髓系恶性肿瘤中的应用：当前数据与未来方向
errEXPERT REVIEW OF ANTICANCER THERAPY
IF2.8
err2025-03-28
err0
PREAI
errBidikian, Aram; Bewersdorf, Jan P.; Kewan, Tariq; Podoltsev, Nikolai A.; Stahl, Maximilian; Zeidan, Amer M.
err分享
err收藏
A niche driven mechanism determines response and a mutation-independent therapeutic approach for myeloid malignancies一个利基驱动的机制决定了反应，并提出了一种与突变无关的治疗方法，用于髓系恶性肿瘤。
errCancer Cell
IF44.5
err2025-03-27
err0
PREAI
errIoanna Mosialou; Abdullah M. Ali; Rossella Labella; Brygida Bisikirska; Alvaro Cuesta-Dominguez; Paraskevi Vgenopoulou; Ismarc Reyes; Sanjana M. Rao; Anqi Wang; Na Luo; Marta Galan-Diez; Junfei Zhao; Brian J. Chernak; Jan Philipp Bewersdorf; Kazuya Fukasawa; Jiayu Su; Jason Higa; Rachel A. Adams; Adam L. Corper; Sergey Pampou; Catherine M. Woods; Xiaomin Fan; Roshan P. Shah; Julie Feldstein; Na Liu; Cui Liang; Maël Heiblig; Steven Kornblau; Guillermo Garcia-Manero; Ellin Berman; Joseph G. Jurcic; Raul Rabadan; Azra Raza; Stavroula Kousteni
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
V
Vijay K. Kuchroo
H 指数: 157 · 论文数: 682
D
Donna Neuberg
H 指数: 155 · 论文数: 1.7K
G
Guillermo Garcia‐Manero
H 指数: 149 · 论文数: 2.9K
R
Ross L. Levine
H 指数: 147 · 论文数: 1.5K
M
Martin S. Tallman
H 指数: 134 · 论文数: 1.3K
查看更多